Comparison of expression and epigenetic profiles from biospecimens between patients and controls is currently one of the major strategies to elucidate disease mechanisms and to identify biomarkers (Cooper-Knock et al., 2012) . A major barrier in applying this strategy for brain disorders is the difficulty in accessing cells and tissues relevant to the disease pathophysiology (Dolmetsch and Geschwind, 2011) . Olfactory tissue obtained by nasal biopsy has been suggested as a surrogate biospecimen for the brain (Borgmann-Winter et al., 2009; Cascella et al., 2007; Feron et al., 1995 Feron et al., , 1998 Girard et al., 2011; Gomez et al., 2000; Hahn et al., 2005; Mackay-Sim et al., 2008; Murrell et al., 2005; Sawa and Cascella, 2009; Talamo et al., 1989; Trojanowski et al., 1991 the validity and limitations of using olfactory tissues have not been systematically addressed. In this study, we aim to address this question by comparing expression profiles among olfactory cells, blood cells, stem cells, and brain tissues. Lymphoblasts were generated according to a published protocol (Bader et al., 2012; Penno et al., 1993) . Dissociated olfactory cells were purified from the olfactory epithelium, which was obtained via rapid nasal biopsy under local anesthesia, as previously described (Kano et al., 2013; Tajinda et al., 2010) . Induced pluripotent stem cells and the neurospheres originated from stem cells were generated according to a published protocol (Imaizumi et al., 2012) . The experimental details of cells in this study are summarized in Supplementary Table. This study was approved by Institutional Review Boards at Johns Hopkins University (NA00037204) and Keio University (20-16-18) .
Supplementary material related to this article can be found, in the online version, at http://dx.doi.org/10.1016/ j.neures.2013.09.010.
We conducted expression profile analysis using Affymetrix U133 Plus 2.0 GeneChip ® with standard protocols (Affimetrix),
